Abstract
Purpose
Surgery of the primary tumor in patients with colorectal cancer and unresectable synchronous liver metastases remains controversial. This study was designed to evaluate predictive preoperative factors of early postoperative death (<3 months) in such patients.
Methods
This study included 80 patients who underwent colorectal resection (n--6) or diversion stoma (n--4) for colorectal cancer with unresectable liver metastases. Twenty-two patients (28 percent) died during the first three months after surgery with two (2.5 percent) in-hospital postoperative deaths. Analysis of predictive preoperative factors for three-month postoperative death risk was performed.
Results
In univariate analysis, age older than 75 years (P--.01), American Society of Anesthesiologists grade > II (P--.009), symptomatic patient (P--.01), bowel obstruction (P--.03), aspartate aminotransferase serum level >50 (1.5 N) IU/L (P--.008), and alkaline phosphatase >200 (2 N) IU/L (P--.02) were prognostic risk factors for three-month death after surgery. In multivariate analysis, age older than 75 years (relative risk--.9; P--.04) and aspartate aminotransferase serum level >50 IU/L (relative risk--.3; P--.03) were independent risk factors.
Conclusions
In patients with colorectal cancer and synchronous unresectable liver metastases, the three-month mortality rate was high (28 percent). Thus, better knowledge of risk factors could help select patients who could possibly benefit from surgery. The study suggested that age older than 75 years and liver cytolysis (>1.5 N) are associated with an increased three-month postoperative death risk. In these patients, surgery should be avoided.
Similar content being viewed by others
References
Faivre J, Manfredi S, Bouvier AM. Epidemiology of colorectal cancer liver metastases. Bull Acad Natl Med 2003;187:815-2.
Al-Sanea N, Isbister WH. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control? ANZ J Surg 2004;74:229-2.
Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722-.
Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Cheng S, Chen CM. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003;46:1646-2.
Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6:651-.
Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005;92:1155-0.
Tebbutt NC, Norman AR, Cunningham D, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003;52:568-3
Carne PW, Frye JN, Robertson GM, Frizelle FA. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 2004;47:1455-1
Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846-0.
Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 2005;89:211-.
Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000;135:530-.
Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer–is it worthwhile? Dis Colon Rectum 1997;40:11-.
Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 2004;22:3475-4.
Sarela A, O’Riordain DS. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001;88:163-.
Law WL, Choi HK, Lee YM, Chu KW. Palliation for advanced malignant colorectal obstruction by self-expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum 2004;47:39–43.
Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000;321:531-
Michel P, Roque I, Di Fiore F, et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumour be resected? Gastroenterol Clin Biol 2004;28:434-.
Acknowledgement
The authors thank Edouardo Flores Rivera, M.D. for assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Read at the meeting of The American Society of Colon and Rectal Surgeons, Philadelphia, Pennsylvania, April 30 to May 5, 2005.
About this article
Cite this article
Vibert, E., Bretagnol, F., Alves, A. et al. Multivariate Analysis of Predictive Factors for Early Postoperative Death After Colorectal Surgery in Patients with Colorectal Cancer and Synchronous Unresectable Liver Metastases. Dis Colon Rectum 50, 1776–1782 (2007). https://doi.org/10.1007/s10350-007-9025-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-007-9025-2